ATE335493T1 - 3-deazaadenosin zur vorbeugung der atherosklerose und mit transplantat assoziierten vaskulopathie - Google Patents

3-deazaadenosin zur vorbeugung der atherosklerose und mit transplantat assoziierten vaskulopathie

Info

Publication number
ATE335493T1
ATE335493T1 AT99946099T AT99946099T ATE335493T1 AT E335493 T1 ATE335493 T1 AT E335493T1 AT 99946099 T AT99946099 T AT 99946099T AT 99946099 T AT99946099 T AT 99946099T AT E335493 T1 ATE335493 T1 AT E335493T1
Authority
AT
Austria
Prior art keywords
deazaadenosine
transplant
preventing atherosclerosis
associated vasculopathy
vasculopathy
Prior art date
Application number
AT99946099T
Other languages
English (en)
Inventor
Werner Haberbosch
Original Assignee
Kerckhoff Klinik Ges Mit Besch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kerckhoff Klinik Ges Mit Besch filed Critical Kerckhoff Klinik Ges Mit Besch
Application granted granted Critical
Publication of ATE335493T1 publication Critical patent/ATE335493T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
AT99946099T 1998-09-03 1999-09-02 3-deazaadenosin zur vorbeugung der atherosklerose und mit transplantat assoziierten vaskulopathie ATE335493T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98116658 1998-09-03

Publications (1)

Publication Number Publication Date
ATE335493T1 true ATE335493T1 (de) 2006-09-15

Family

ID=8232575

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99946099T ATE335493T1 (de) 1998-09-03 1999-09-02 3-deazaadenosin zur vorbeugung der atherosklerose und mit transplantat assoziierten vaskulopathie

Country Status (7)

Country Link
US (3) US6693088B1 (de)
EP (1) EP1107765B1 (de)
AT (1) ATE335493T1 (de)
AU (1) AU5858899A (de)
DE (1) DE69932728T2 (de)
ES (1) ES2270614T3 (de)
WO (1) WO2000013691A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE335493T1 (de) * 1998-09-03 2006-09-15 Kerckhoff Klinik Ges Mit Besch 3-deazaadenosin zur vorbeugung der atherosklerose und mit transplantat assoziierten vaskulopathie
DE10124820A1 (de) 2001-05-21 2002-12-05 Heinrich Wieland Zusammensetzung und Verwendung von Substanzen zur Stabilisierung von schwefelhaltigen Aminosäuren im Blut
US8814937B2 (en) 2008-09-18 2014-08-26 Peter L. Mayer Intervertebral disc prosthesis, method for assembling, method for implanting prosthesis, and method for explanting
US8187333B2 (en) 2008-09-18 2012-05-29 Mayer Peter L Intervertebral disc prosthesis and method for implanting and explanting
US9393126B2 (en) 2012-04-20 2016-07-19 Peter L. Mayer Bilaterally placed disc prosthesis for spinal implant and method of bilateral placement
US9364339B2 (en) 2012-04-30 2016-06-14 Peter L. Mayer Unilaterally placed expansile spinal prosthesis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1164735B (it) 1978-10-13 1987-04-15 Wellcome Found Derivati adenosinici e procedimento per la loro preparazione
GB2074858B (en) 1980-04-23 1985-03-20 Wellcome Found Compositions containing 3-deazaaden-osine
US4322411A (en) * 1980-04-25 1982-03-30 Burroughs Wellcome Co. Anti-inflammatory nucleosides
DK0441516T3 (da) * 1990-02-08 1995-06-12 Howmedica Oppusteligt kateter
US20030203976A1 (en) * 1993-07-19 2003-10-30 William L. Hunter Anti-angiogenic compositions and methods of use
ATE335493T1 (de) * 1998-09-03 2006-09-15 Kerckhoff Klinik Ges Mit Besch 3-deazaadenosin zur vorbeugung der atherosklerose und mit transplantat assoziierten vaskulopathie

Also Published As

Publication number Publication date
US20040106563A1 (en) 2004-06-03
US20100106244A1 (en) 2010-04-29
WO2000013691A3 (en) 2000-06-02
ES2270614T3 (es) 2007-04-01
EP1107765A2 (de) 2001-06-20
US7785614B2 (en) 2010-08-31
EP1107765B1 (de) 2006-08-09
US6693088B1 (en) 2004-02-17
AU5858899A (en) 2000-03-27
DE69932728D1 (de) 2006-09-21
US8158142B2 (en) 2012-04-17
WO2000013691A9 (en) 2000-08-10
DE69932728T2 (de) 2007-09-06
WO2000013691A2 (en) 2000-03-16

Similar Documents

Publication Publication Date Title
DE69632390D1 (de) Implantierbare vaskuläre und endoluminale Stents
DE69433478D1 (de) Verwendung von stickoxid-addukten zur verhütung von thrombosen auf artifiziellen und vaskulären oberflächen
DE69827192D1 (de) Stent und Stent-Transplantat zur Behandlung von verzweigten Blutgefässen
DE69736343D1 (de) Vaskuläre und endoluminale Stents
ITTO930940A0 (it) Innesto protesico vascolare
DE69530891D1 (de) Bistabile luminale Transplantat-Endoprothesen
DE69316751D1 (de) Azlaktonfunktionen aufweisende substrate, hornhautprothesen und ihre verwendung
DE69131127D1 (de) Verbindungen und artikel zur geruchsbegrenzung
DE59811925D1 (de) Stent zur behandlung pathologischer körpergefässe
AU1724099A (en) Vascular stent for reduction of restenosis
DE59611411D1 (de) Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
DE69806579D1 (de) Anlage zur behandlung von nahrungsmitteln
DE69814950D1 (de) Mit Hydroxyapatit beschichtete Prothesenimplantate und Verfahren zur Behandlung von Prothesenimplantaten die mit Hydroxyapatit plasmagespritzt sind
EP1441749A4 (de) Gefässstent oder implantat, der bzw. das mit protein-tyrosinkinase-hemmern beschichtet oder imprägniert ist und anwendungsverfahren dafür
DE69841041D1 (de) Stent beschichtet mit dna
DE69920031D1 (de) Verwendung von vegf-c und vegf-d genen oder proteinen zur vorbeugung der restenose
DE69612465D1 (de) Verwendung von Rifamyciderivaten zur Behandlung von Chlamydia-Infektionen
DK0896544T3 (da) Kombination af en somatostatinanalog og en rapamycin
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
ATE335493T1 (de) 3-deazaadenosin zur vorbeugung der atherosklerose und mit transplantat assoziierten vaskulopathie
ATE261434T1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE69637641D1 (de) Auf rapamycin basierende regulation biologischer vorgänge
HUP0202085A3 (en) Use of levosimendan for the treatment or prevention of coronary graft vasospasm
DK0869813T3 (da) Anvendelse af beta-interferoner til behandling af restenose

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1107765

Country of ref document: EP